Dr. Yuanying Zeng has nearly two decades of clinical experience in adult hematology, with long-standing expertise in the comprehensive management of a wide range of hematologic diseases, including acute leukemia, myelodysplastic syndromes (MDS), multiple myeloma, aplastic anemia, and hereditary blood disorders. She has extensive frontline experience in hematopoietic stem cell transplantation (HSCT), having led or participated in more than 200 transplant procedures. Dr. Zeng is highly skilled in managing complex and high-risk transplant cases, demonstrating steady clinical judgment and strong technical proficiency.
Dr. Zeng is particularly experienced in TCRαβ-depleted Haploidentical HSCT (TDH) and has developed systematic and mature transplantation practices for adult acute leukemia, MDS, aplastic anemia, adult thalassemia, and plasma cell disorders. She is also actively involved in advancing combined CAR-T cell therapy and HSCT strategies, enabling her to design individualized treatment pathways based on disease characteristics and patient-specific needs. Her work promotes the deep integration and innovative application of cellular immunotherapy and transplantation medicine.
